[Gingival hyperplasia associated with amlodipine].
Drug-induced gingival hyperplasia is a well documented unwanted side effect within the literature. It has been associated with the use of three different types of pharmaceutical agents, including phenytoin, cyclosporine and calcium channel blocking agents. Amlodipine belongs to the dihydropyridine-derived calcium blocking agents that may cause the side effect of drug-induced gingival hyperplasia. In the present study the possible pathogenic mechanisms, clinical and histologic presentation and therapeutic indications of amlodipine-induced gingival hyperplasia are discussed.
Infante Cossío
P
P
Servicio de Cirugía Maxilo Facial y Estomatología, Hospital Universitario Virgen del Rocío, Sevilla.
Torelló Iserte
J
J
Espín Gálvez
F
F
García-Perla
A
A
Rodríguez-Armijo Sánchez
L
L
Castillo Ferrando
J R
JR
D000368:Aged; D017311:Amlodipine / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced*; D006801:Humans
D002121:Calcium Channel Blockers; D017311:Amlodipine